Insider · CIK 0001824542

Beskrovnaya Oxana

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001824542

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-03-11	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,153 sh	$11.38	−$24.5K	195,840
2025-03-05	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,094 sh	$11.83	−$12.9K	197,993
2025-02-18	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,598 sh	$13.95	−$36.2K	199,087
2024-12-11	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,334 sh	$28.12	−$65.6K	201,685
2024-12-04	DYNDyne Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+39.1K sh	—	—	176,619
2024-12-04	DYNDyne Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+27.4K sh	—	—	204,019
2024-12-04	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Chief Scientific Officer	AAward	+62.4K sh	—	—	62,400
2024-11-18	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,856 sh	$28.20	−$80.5K	137,519
2024-09-18	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,339 sh	$34.55	−$80.8K	140,375
2024-09-11	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,161 sh	$31.89	−$68.9K	142,714
2024-08-19	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−296 sh	$46.00	−$13.6K	144,875
2024-08-19	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,340 sh	$45.01	−$105K	145,171
2024-06-11	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,136 sh	$31.34	−$66.9K	147,511
2024-05-20	DYNDyne Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−30.4K sh	—	—	0
2024-05-20	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,145 sh	$34.08	−$39K	149,647
2024-05-20	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−12.1K sh	$33.51	−$407K	150,792
2024-05-20	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−17.1K sh	$32.49	−$557K	162,939
2024-05-20	DYNDyne Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+30.4K sh	$1.03	+$31.3K	180,073
2024-05-16	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,222 sh	$28.20	−$62.7K	150,130
2024-05-16	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−483 sh	$28.59	−$13.8K	149,647
2024-03-11	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,081 sh	$25.70	−$53.5K	152,352
2024-03-07	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,373 sh	$25.85	−$61.3K	154,433
2024-01-04	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−42.5K sh	$18.13	−$770K	156,806
2024-01-04	DYNDyne Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+22.7K sh	$1.03	+$23.4K	199,259
2024-01-03	DYNDyne Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+45.3K sh	$1.03	+$46.7K	221,911
2024-01-03	DYNDyne Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−45.3K sh	—	—	53,100
2024-01-03	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−5,361 sh	$20.50	−$110K	176,585
2024-01-03	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−24.6K sh	$19.05	−$468K	181,946
2024-01-03	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−15.4K sh	$18.34	−$282K	206,529
2023-12-11	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,467 sh	$10.72	−$15.7K	176,585
2023-11-15	DYNDyne Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+93.7K sh	—	—	178,052
2023-11-15	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+36.5K sh	—	—	36,495
2023-09-18	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,436 sh	$9.41	−$13.5K	84,334
2023-09-12	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,484 sh	$10.41	−$15.4K	85,770
2023-06-13	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,475 sh	$12.43	−$18.3K	87,254
2023-03-14	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,416 sh	$13.33	−$18.9K	88,729
2023-01-04	DYNDyne Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−22.7K sh	—	—	30,426
2022-12-12	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−680 sh	$10.87	−$7,391.6	90,145
2022-12-09	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+63K sh	—	—	63,000
2022-12-09	DYNDyne Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+40K sh	—	—	90,825
2022-09-20	DYNDyne Therapeutics, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−1,413 sh	$13.70	−$19.4K	50,825
2022-09-15	DYNDyne Therapeutics, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−712 sh	$14.05	−$10K	52,238
2022-07-05	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+23.5K sh	—	—	23,477
2022-06-14	DYNDyne Therapeutics, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−726 sh	$4.95	−$3,593.7	52,950
2022-03-11	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−693 sh	$8.73	−$6,049.89	53,676
2021-12-10	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+54.8K sh	—	—	54,786
2021-12-10	DYNDyne Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+36.5K sh	—	—	54,369
2021-09-21	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−827 sh	$16.11	−$13.3K	17,845
2021-09-20	DYNDyne Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−617 sh	$15.61	−$9,631.37	18,672
2021-06-02	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+110K sh	—	—	110,000

Recent filings

Accepted (ET)
Mar 134
Beskrovnaya Oxana0000950170-25-038726
SEC(opens sec.gov)
Mar 74
Beskrovnaya Oxana0000950170-25-035472
SEC(opens sec.gov)
Feb 254
Beskrovnaya Oxana0000950170-25-026837
SEC(opens sec.gov)
Dec 114
Beskrovnaya Oxana0000950170-24-135571
SEC(opens sec.gov)
Dec 64
Beskrovnaya Oxana0000950170-24-134070
SEC(opens sec.gov)
Nov 184
Beskrovnaya Oxana0000950170-24-127989
SEC(opens sec.gov)
Sep 194
Beskrovnaya Oxana0000950170-24-108151
SEC(opens sec.gov)
Sep 114
Beskrovnaya Oxana0000950170-24-105517
SEC(opens sec.gov)
Aug 204
Beskrovnaya Oxana0000950170-24-099122
SEC(opens sec.gov)
Jun 114
Beskrovnaya Oxana0000950170-24-072170
SEC(opens sec.gov)
May 224
Beskrovnaya Oxana0000950170-24-063737
SEC(opens sec.gov)
May 174
Beskrovnaya Oxana0000950170-24-062080
SEC(opens sec.gov)

Companies

Dyne Therapeutics, Inc.Chief Scientific OfficerDYN

Address

C/O DYNE THERAPEUTICS, INC. 1560 TRAPELO ROAD

WALTHAM, MA, 02451